Wecome Pharmaceutical Co Ltd (300878)

Shenzhen

Currency in CNY

23.85

-1.15(-4.60%)

Closed·08:44:59

Fair Value

Unlock Value

Day's Range

23.57

25.33

52 wk Range

13.08

29.30

300878 Financial Summary

A brief financial summary of Wecome Pharmaceutical Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-15.74

Price/Book2.48

Debt / Equity25.13%

Return on Equity-14.06%

Dividend Yield0.56%

EBITDA-103.25M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2023

01/01

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

622.77

632.95

532.44

519.62

351.2

Gross Profit

aa.aa

451.35

428.57

313.36

261.93

127.8

Operating Income

aa.aa

122.8

83.62

54.24

-19.9

-161.53

Net Income

aa.aa

135.82

96.5

48.81

-8.95

-147.43

Balance Sheet

Total Assets

aa.aa

1,628.78

1,693.31

1,914.53

2,061.75

1,652.32

Total Current Liabilities

aa.aa

213.65

232.4

413.07

445.55

240.38

Total Equity

aa.aa

1,384.39

1,409.02

1,411.04

1,408.2

1,173.83

Cash Flow

Levered Free Cash Flow

aa.aa

-145.36

-304.93

-405.82

316

-84.38

Cash from Operations

aa.aa

42.81

-67.74

145.18

58.29

-27.17

Cash from Investing

aa.aa

-172.27

-192.35

-442.43

9.31

188.29

Cash from Financing

aa.aa

568.89

-53.96

178.74

97.57

-234.09

Net Change in Cash

aa.aa

439.43

-314.06

-118.51

165.17

-72.97

* In Millions of CNY (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS -1.27%

Dividend Yield

0.59%

Industry Median 1.51%

Annualised payout

0.14

Paid annually

5-Years Growth

Growth Streak

Unlock

Earnings

Latest Release

Apr 28, 2025

EPS / Forecast

-0.07 / --

Revenue / Forecast

69.78M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Wecome's earnings for the latest quarter?

The Wecome EPS (TTM) is -1.27. Wecome reported sales of 69.78, net income of -9.85, and EPS of -0.07 for the latest quarter.

What was Wecome's net income for the latest quarter?

Wecome's net income for the latest quarter was -9.85.

How did Wecome's performance compare year-over-year in the latest quarter?

The company's revenue moved from -19.65 in the previous quarter to 69.78 in the latest quarter, and net income moved from -191.52 to -9.85 compared to the previous quarter.

What is Wecome's net profit margin on a TTM basis?

Wecome's trailing twelve months (TTM) net profit margin is -41.98%.

How does Wecome's debt to equity ratio compare to industry standards?

Wecome's total debt-to-equity ratio is 25.13%.

What is Wecome's return on investment on a TTM basis?

Wecome's trailing twelve months (TTM) return on investment (ROI) is -14.06%.

Did Wecome gain or lose cash last quarter?

In the latest quarter, Wecome's net change in cash was 6.20 million.

What were Wecome's total assets and liabilities in the latest quarter?

As of the latest quarter, Wecome reported total assets of 1,638.65 million and total liabilities of 228.09 million.

How has Wecome's total revenue grown this year?

Wecome's total revenue was -19.65 in the previous quarter and 69.78 in the latest quarter.

What is Wecome's gross margin on a TTM basis?

Wecome's trailing twelve months (TTM) gross margin is 29.79%.

What was Wecome's revenue per share for the latest quarter?

Wecome's revenue per share for the latest quarter was 6.96.

NSE 30

5,328.61

-1.12

-0.02%

NSE All Share

146,055.88

+107.40

+0.07%

US 30

44,461.30

+485.4

+1.10%

US 500

6,441.10

+67.6

+1.06%

FTSE 100

9,147.81

+18.10

+0.20%

DAX

24,050.12

-31.22

-0.13%

South Africa Top 40

93,808.58

+525.91

+0.56%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.55	-0.54%	61.09M
Zenith Bank	74.00	0.00%	27.39M
Nigerian Breweries	74.40	0.00%	27.12M
Guaranty Trust Holding	99.00	-0.85%	26.50M
UBA	48.70	+1.25%	17.85M
Dangote Cement	577.00	0.00%	4.44M
Aradel Holdings	520.00	0.00%	1.89M

Name	Last	Chg. %	Vol.
Prestige	2.20	+10.00%	7.86M
Champion Brew	17.38	+10.00%	6.86M
Mansard Ins	17.710	+10.00%	4.73M
Sunu Assurances	6.05	+10.00%	13.54M
Abctrans	4.95	+10.00%	1.49M
Initiates	14.52	+10.00%	4.88M
Ellah Lakes	16.06	+10.00%	26.26M

Name	Last	Chg. %	Vol.
Juli	9.00	-10.00%	101.69K
Unilever Nigeria	71.30	-9.97%	4.19M
Custodian Allied	37.90	-9.55%	1.87M
Academy Press	8.30	-7.78%	1.07M
Maybaker	18.000	-7.69%	1.69M
Wema Bank	21.75	-6.05%	3.91M
Livestock	8.45	-5.06%	4.09M

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	4.23	+9.87%	64.99M
Linkassure	2.48	+9.73%	11.77M
Access Holdings	27.55	-0.54%	61.09M
Ellah Lakes	16.06	+10.00%	26.26M
Mutual Benefits Assurance	3.53	+9.97%	30.37M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa A	5,450.00	+42.64%	7,773.88
Aaaaaaa	577.00	+40.93%	813.17
Aaaa Aaa	1,890.00	+34.32%	2,538.65
A Aaaa	71.00	+26.96%	90.14
A Aaaaaaaaaaaaa	168.60	+26.01%	212.45
Aaaa A A	640.00	+16.86%	747.90

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Wecome Pharmaceutical Co Ltd (300878)

300878 Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Wecome's earnings for the latest quarter?

What was Wecome's net income for the latest quarter?

How did Wecome's performance compare year-over-year in the latest quarter?

What is Wecome's net profit margin on a TTM basis?

How does Wecome's debt to equity ratio compare to industry standards?

What is Wecome's return on investment on a TTM basis?

Did Wecome gain or lose cash last quarter?

What were Wecome's total assets and liabilities in the latest quarter?

How has Wecome's total revenue grown this year?

What is Wecome's gross margin on a TTM basis?

What was Wecome's revenue per share for the latest quarter?

Trending Stocks